Segment Information - Schedule of CODM expense categories (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Operating Expenses [Abstract] | ||||||
| Clinical and manufacturing | $ 2,840 | $ 898 | $ 4,500 | $ 1,408 | ||
| General and administrative | 1,610 | 684 | 3,746 | 1,396 | ||
| Loss from operations | (4,450) | (1,582) | (8,246) | (2,804) | ||
| Total other expense, net | 52 | 309 | 10 | 796 | ||
| Net loss | (4,502) | $ (3,754) | (1,891) | $ (1,709) | (8,256) | (3,600) |
| Operating Segments [Member] | ||||||
| Operating Expenses [Abstract] | ||||||
| Clinical and manufacturing | 1,812 | 184 | 2,484 | 373 | ||
| Other research and development | 1,028 | 714 | 2,016 | 1,035 | ||
| Total research and development | 2,840 | 898 | 4,500 | 1,408 | ||
| General and administrative | 1,610 | 684 | 3,746 | 1,396 | ||
| Loss from operations | (4,450) | (1,582) | (8,246) | (2,804) | ||
| Other expense, net | 52 | 309 | 10 | 796 | ||
| Total other expense, net | 52 | 309 | 10 | 796 | ||
| Net loss | $ (4,502) | $ (1,891) | $ (8,256) | $ (3,600) | ||
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|